These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 19262672)
21. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Poyart C; Pellegrini E; Marceau M; Baptista M; Jaubert F; Lamy MC; Trieu-Cuot P Mol Microbiol; 2003 Sep; 49(6):1615-25. PubMed ID: 12950925 [TBL] [Abstract][Full Text] [Related]
22. Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery? Parsons JB; Rock CO Curr Opin Microbiol; 2011 Oct; 14(5):544-9. PubMed ID: 21862391 [TBL] [Abstract][Full Text] [Related]
23. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis]. Zhu M; Hu Q; Mai J; Lin Z Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405 [TBL] [Abstract][Full Text] [Related]
24. [Phenotypic characterization of Streptococcus agalactiae strains isolated from urocultures]. Muntean D; Licker M; Berceanu-Văduva D; Hogea E; Crăciunescu M; Piluţ C; Popa M; Rădulescu M; Lăcătuş R; Serban D; Moldovan R Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):19-23. PubMed ID: 19241993 [TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of the antibacterial activities of radezolid and linezolid for Streptococcus agalactiae. Zheng JX; Chen Z; Xu ZC; Chen JW; Xu GJ; Sun X; Yu ZJ; Qu D Microb Pathog; 2020 Feb; 139():103866. PubMed ID: 31715321 [TBL] [Abstract][Full Text] [Related]
26. Bacterial fatty acid metabolism in modern antibiotic discovery. Yao J; Rock CO Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701 [TBL] [Abstract][Full Text] [Related]
27. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul. Tariq TM J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929 [TBL] [Abstract][Full Text] [Related]
30. Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Stratford RE; Cooper RD Antimicrob Agents Chemother; 1995 Nov; 39(11):2585-7. PubMed ID: 8585753 [TBL] [Abstract][Full Text] [Related]
31. Severe Group A and Group B Streptococcus Diseases at a Pediatric ICU: Are they Still Sensitive to the Penicillins? Hon KL; Chow TC; Cheung TS; Lam WT; Hung LT; So KW; Margaret IP; Qian SY Curr Clin Pharmacol; 2020; 15(2):125-131. PubMed ID: 31556861 [TBL] [Abstract][Full Text] [Related]
32. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds. Jones RN; Low DE; Pfaller MA Diagn Microbiol Infect Dis; 1999 Feb; 33(2):101-12. PubMed ID: 10091033 [TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial susceptibility of Streptococcus agalactiae strains in Monastir]. Sahnoun O; Ben Abdallah H; Noomen S; Ben Elhadj Khélifa A; Mastouri M Med Mal Infect; 2007 Nov; 37(11):734-7. PubMed ID: 17459635 [TBL] [Abstract][Full Text] [Related]
34. Streptococcus agalactiae, an emerging pathogen for cultured ya-fish, Schizothorax prenanti, in China. Geng Y; Wang KY; Huang XL; Chen DF; Li CW; Ren SY; Liao YT; Zhou ZY; Liu QF; Du ZJ; Lai WM Transbound Emerg Dis; 2012 Aug; 59(4):369-75. PubMed ID: 22146014 [TBL] [Abstract][Full Text] [Related]
35. A novel bioengineered derivative of nisin displays enhanced antimicrobial activity against clinical Streptococcus agalactiae isolates. Hayes K; Field D; Hill C; O'Halloran F; Cotter L J Glob Antimicrob Resist; 2019 Dec; 19():14-21. PubMed ID: 31054335 [TBL] [Abstract][Full Text] [Related]
36. Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital. Acikgoz ZC; Almayanlar E; Gamberzade S; Gocer S Antimicrob Agents Chemother; 2004 Apr; 48(4):1410-2. PubMed ID: 15047555 [TBL] [Abstract][Full Text] [Related]
37. Multiple-Clones of Streptococcus agalactiae harbouring lnuB gene. Faccone D; Lalonardi F; Abel S; Machain M; Errecalde L; Littvik A; Kauffman S; Galas M; ; Corso A J Infect Dev Ctries; 2010 Oct; 4(9):580-2. PubMed ID: 21045372 [No Abstract] [Full Text] [Related]
38. Serotypes, genotypes, and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitis before and after introduction of antibiotic prophylaxis. Trijbels-Smeulders MA; Kimpen JL; Kollée LA; Bakkers J; Melchers W; Spanjaard L; Wannet WJ; Hoogkamp-Korstanje MA Pediatr Infect Dis J; 2006 Oct; 25(10):945-8. PubMed ID: 17006295 [TBL] [Abstract][Full Text] [Related]